DJ Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved
Hardman & Co Research Hardman & Co Research on Advanced Oncotherapy: Major milestone achieved 29-Sep-2022 / 07:15 GMT/BST
-----------------------------------------------------------------------------------------------------------------------
Hardman & Co Research on Advanced Oncotherapy:
Major milestone achieved
AVO's goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology, developed originally at the world-renowned CERN. The complex assembly of its first LIGHT accelerator in Daresbury has been completed and demonstrated to generate a full-energy proton beam (230MeV) required to treat deep-seated tumours. AVO is now working with its clinical partner, University Hospitals Birmingham NHS Foundation Trust (UHB), to commission the treatment room and prepare for regulatory certification. This significant de-risking of the project paves the way for further commercial deals.
Please click on the link below for the full report:
https://hardmanandco.com/research/corporate-research/major-milestone-achieved/
If you are interested in meeting the company, you can register your interest by clicking on the above link
To contact us:
Hardman & Co Contact:
1 Frederick's Place
Martin Hall
London mh@hardmanandco.com
EC2R 8AE
+44(0)203 693 7075
www.hardmanandco.com
Follow us on Twitter @HardmanandCo
Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.
About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
End of Announcement - EQS News Service
1452593 29-Sep-2022
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1452593&application_name=news
(END) Dow Jones Newswires
September 29, 2022 02:15 ET (06:15 GMT)